NasdaqGM - Nasdaq Real Time Price USD

Artiva Biotherapeutics, Inc. (ARTV)

Compare
2.5000
-0.0400
(-1.57%)
As of 9:37:57 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
251
251
33,492
4,931
2,002
Operating Expense
67,533
67,533
64,163
64,760
55,274
Operating Income
-67,282
-67,282
-30,671
-59,829
-53,272
Net Non Operating Interest Income Expense
5,349
5,349
2,535
1,294
--
Other Income Expense
3,440
3,440
512
200
-18,553
Pretax Income
-58,493
-58,493
-27,624
-58,335
-71,825
Tax Provision
--
--
72
53
--
Net Income Common Stockholders
-58,493
-58,493
-27,696
-58,388
-71,825
Diluted NI Available to Com Stockholders
-58,493
-58,493
-27,696
-58,388
-71,825
Basic EPS
-2.48
-5.81
-1.19
-6.24
-7.67
Diluted EPS
-2.48
-5.81
-1.19
-6.24
-7.67
Basic Average Shares
24,287.1440
11,258.8510
23,281.5610
9,361.5610
9,361.5610
Diluted Average Shares
24,287.1440
11,258.8510
23,281.5610
9,361.5610
9,361.5610
Total Operating Income as Reported
-67,282
-67,282
-30,671
-59,829
-53,272
Total Expenses
67,533
67,533
64,163
64,760
55,274
Net Income from Continuing & Discontinued Operation
-58,493
-58,493
-27,696
-58,388
-71,825
Normalized Income
-62,090
-62,090
-28,254.5300
-58,388
-71,825
Interest Income
5,349
5,349
2,535
1,294
--
Net Interest Income
5,349
5,349
2,535
1,294
--
EBIT
-67,282
-67,282
-30,671
-59,829
-71,825
EBITDA
-64,851
-64,851
-28,405
-58,671
-71,577
Reconciled Depreciation
2,431
2,431
2,266
1,158
248
Net Income from Continuing Operation Net Minority Interest
-58,493
-58,493
-27,696
-58,388
-71,825
Total Unusual Items Excluding Goodwill
3,597
3,597
707
--
--
Total Unusual Items
3,597
3,597
707
--
--
Normalized EBITDA
-68,448
-68,448
-29,112
-58,671
-71,577
Tax Rate for Calcs
--
--
0.0002
0.0002
--
Tax Effect of Unusual Items
--
--
148.4700
--
--
12/31/2021 - 7/19/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MBX MBX Biosciences, Inc.
6.42
+0.78%
 
KYTX Kyverna Therapeutics, Inc.
1.9074
-3.18%
 
ATXS Astria Therapeutics, Inc.
4.8500
-5.83%
 
TYRA Tyra Biosciences, Inc.
7.96
-4.07%
 
CLYM Climb Bio Inc
1.1091
-3.58%
 
CTNM Contineum Therapeutics, Inc.
5.85
-4.57%
 
BOLD Boundless Bio, Inc.
1.3550
-1.78%
 
ZBIO Zenas BioPharma, Inc.
7.22
-7.44%
 
RAPP Rapport Therapeutics, Inc.
7.94
-6.81%
 
AVBP ArriVent BioPharma, Inc.
16.55
-2.28%